Skip to main content
Clinical Trials/NCT02883816
NCT02883816
Completed
Not Applicable

Early Assessment of Respiratory Function, Inflammation and Bronchial Reshuffle Among Newborns Screened for Cystic Fibrosis

University Hospital, Montpellier1 site in 1 country52 target enrollmentAugust 2008
ConditionsCystic Fibrosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cystic Fibrosis
Sponsor
University Hospital, Montpellier
Enrollment
52
Locations
1
Primary Endpoint
Change from respiratory function at 7 months and 11 months
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The main objective of this study is to show that there is a concordance between lung disease at 13 months and the existing 9 weeks in newborn babies with cystic fibrosis asymptomatically.

This will identify at the first examination at 8 weeks, newborns who have the most impaired lung function at 13 months. To meet this objective an assessment of their lung function at 9 weeks and 1 month will be performed in newborns diagnosed with cystic fibrosis.

Registry
clinicaltrials.gov
Start Date
August 2008
End Date
January 2014
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change from respiratory function at 7 months and 11 months

Time Frame: 7 months and 11 months

measurement of lung volumes and flow rates of bronchial

Study Sites (1)

Loading locations...

Similar Trials